New Data and Recent Approval in China Cements Galderma’s Leadership in Regenerative Biostimulation November 4, 2024
The Board of Directors of Metacon has resolved on a rights issue of approximately SEK 138 million, conditional on the approval of the extraordinary general meeting October 16, 2024
The Board of Railway Metrics and Dynamics Sweden AB (publ) resolves on a partially guaranteed rights issue of units for SEK 23.9 million, subject to approval at an extraordinary general meeting October 8, 2024
EU Notified Body (BSI Netherlands) and the EMA Grant Approval of the LeukoStrat® CDx FLT3 Mutation Assay for VANFLYTA® Therapy in the EU and EEA October 8, 2024